Last updated on December 2019

A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis


Brief description of study

The purpose of this research study is to investigate if KY1005 results in improvement of eczema when given to participants with moderate to severe disease. Side effects of KY1005 will also be explored.

Detailed Study Description

Phase 2a, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety and tolerability of two doses of KY1005 in adults with moderate to severe atopic dermatitis whose disease cannot be adequately controlled with topical medications or for whom topical treatment is medically inadvisable.

Clinical Study Identifier: NCT03754309

Find a site near you

Start Over